Oct 7, 2020
For country decision-makers, the opportunity to introduce a new vaccine comes with many considerations. Is the vaccine needed? What are the benefits? Is there enough capacity in the cold chain system? Often most important—what will it cost, and can our country afford it?Read More
Aug 4, 2017
Childhood immunization is one of the best investments a country can make. The world has made great strides in recent years, and we are closer to ensuring that no child is left unreached by lifesaving vaccines. But despite this progress, coverage has stagnated globally, and one in ten infants worldwide don’t receive a single vaccine. Each year, the WHO and UNICEF release an annual report that estimates global immunization coverage. The report offers a snapshot of the world’s progress toward achieving the Global Vaccine Action Plan (GVAP).Read More
Feb 11, 2015
At DefeatDD, we can appreciate the need for strong immunization data. In fact, it was this priority that gave birth to the DefeatDD initiative and our integrated approach to defeating diarrheal disease. Let me back up a few steps.
About eight years ago, PATH and our partners were intensively evaluating then-new rotavirus vaccines’ performance in the countries where the disease hits hardest. We also were helping conduct pivotal surveillance that showed the magnitude of rotavirus morbidity and mortality in the developing world, as well as their potential cost-effectiveness and logistical implications when introduced into national immunization programs. Another part of our role was to share these data and put them in context for Ministers of Health to help inform their decisions when rotavirus vaccines ultimately became available and accessible through WHO prequalification.Read More